Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v1-EN
Language English English
Date Updated 2022-09-28 2022-09-27
Drug Identification Number 02301903 02301903
Brand name CIPROFLOXACIN INJECTION USP CIPROFLOXACIN INJECTION USP
Common or Proper name CIPROFLOXACIN INJECTION USP CIPROFLOXACIN INJECTION USP
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients CIPROFLOXACIN CIPROFLOXACIN
Strength(s) 2MG 2MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 24 x 200mL bag 24 x 200mL bag
ATC code J01MA J01MA
ATC description QUINOLONE ANTIBACTERIALS QUINOLONE ANTIBACTERIALS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2022-09-27 2022-09-27
Remaining supply date 2022-09-27 2022-09-27
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments